Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II trial of KL130008 capsules in moderate to severe active rheumatoid arthritis
ChiCTR2100042141Phase 2Recruiting
- Sponsor
- West China Hospital of Sichuan University
- Start
- Mar 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in rheumatoid arthritis (RA) comparing KL130008 test group with Placebo group (2 arms). Primary endpoints: Serum TNF-alpha, Serum interleukin-6 and 5 more. Started Mar 2021; status: recruiting.
02
Drugs
KL130008
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on ChiCTR2100042141.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100042141.